D. E. Shaw & Co., Inc. Fulgent Genetics, Inc. Call Options Transaction History

D. E. Shaw & Co., Inc.

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$66.8 - $100.45 $1.34 Million - $2.01 Million	-20,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$59.3 - $183.85 $1.19 Million - $3.68 Million	20,000 New	20,000 $1.93 Million

199

14.7M

1.16M

92.9K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $594M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.